openPR Logo
Press release

Medroxyprogesterone Acetate Market: Global Industry Analysis, Growth, Trends and Forecast 2017 – 2025

02-25-2018 08:57 AM CET | Health & Medicine

Press release from: Persistence Market Research

Medroxyprogesterone Acetate Market: Global Industry

The synthetic version of progesterone, 17α-hydroxy-6α-methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected is its acetate derivative. Medroxyprogesterone acetate is administered every 3 months which in turn prevents ovulation and follicular maturation in endometrial thinning producing a contraceptive effect. 

The medroxyprogesterone acetate market is driven by the increasing need for birth control measure and government initiatives to generate more awareness related to the different contraceptive methods. There are various forecasting initiatives undertaken to understand the demand of Depot medroxyprogesterone acetate (DMPA) as a birth control measure. In January 2015, the Concept Foundation contracted William Davidson Institute (WDI), to understand the demand of DMPA in low income and middle-income countries.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/15688

Manufacturers are now trying to develop low-dose injectable of medroxyprogesterone acetate through subcutaneous route so as to lower some of the side effects related to weight gain and metabolic effects.

Sayana Press a three-month, progestin-only injectable contraceptive was approved by the UK authorities in 2015. PATH along with ministries of health in Uganda and Senegal are researching on self-injection of Sayana Press and ways that it could be effective in women. Through the PATH initiatives since 2014, this contraceptive is available in remote locations in Uganda, Senegal, Niger and Burkina Faso.  Sayana Press has regulatory approval in Europe and 25 other countries. In 2014, the Children’s Investment Fund Foundation (CIFF), the Bill & Melinda Gates Foundation and Pfizer Inc. decided to offer Sanaya Press to purchasers from 69 countries for US$1 per dose.             

The public and the private partners announced in the London Summit to reach poorest countries by 2020 with around 12 million doses of Sayana Press. Injctables has always been a popular contraceptive method in Sub-Saharan Africa and hence the presentation of Sayana Press inj the Uniject device is expected to increase the demand. The all-in-one prefiled injection system improves safety and enhances access through non-clinical channels.        
   
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/15688

In terms of geography, medroxyprogesterone acetate market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. The presence of major market players, technology advancements and research investments has made North America the dominating region for the cardiac biomarkers market. Moreover, there are many startups who are trying to enter the medroxyprogesterone acetate market with new technologies and more efficacy.

Developing countries are focusing on bringing down the infact and maternal death rates by legalizing the use of injectable contraceptives. One such initiative was taken by Haryana, which became the first state in the country to implement the use of injectable contraceptives. The project would be initiated in nine blocks of the state where the injectable would be available free of costs in all district hospitals, primary health centers and community health centers.    

Need more information about Report methodology ? @ https://www.persistencemarketresearch.com/methodology/15688

Some of the medroxyprogesterone acetate market participants are Pfizer Inc., Fangtong Pharma.Co.Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd.. 

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Historical Actual Market Size, 2012 - 2014
Market Size & Forecast 2015 to 2024
Supply & Demand Value Chain
Market Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Aircraft Refurbishing Market Drivers and Restraints

Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

View Report Preview @ https://www.persistencemarketresearch.com/market-research/medroxyprogesterone-acetate-market.asp

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Medroxyprogesterone Acetate Market: Global Industry Analysis, Growth, Trends and Forecast 2017 – 2025 here

News-ID: 956346 • Views:

More Releases from Persistence Market Research

Clamp Meter Market Poised for Expansion Amid Rising Electrical Safety and Energy Efficiency Needs
Clamp Meter Market Poised for Expansion Amid Rising Electrical Safety and Energy …
Market Overview The global clamp meter market has become a pivotal segment of the electrical testing and measurement industry, growing at a healthy pace due to rising demand for safe and efficient electrical diagnostics. Valued at US$32.1 billion in 2024, the market is forecast to expand to US$54.3 billion by 2031, reflecting a CAGR of 7.8%. This robust expansion is supported by rapid industrialization, advancements in testing technologies, and heightened emphasis
Bend Testing Machine Market Poised for Expansion with Rising Demand in Construction and Manufacturing
Bend Testing Machine Market Poised for Expansion with Rising Demand in Construct …
Market Overview The global bend testing machine market is forecast to expand at a robust CAGR of 13.5%, increasing from an estimated value of US$58.7 Bn in 2024 to reach US$142.4 Bn by 2031. Bend testing machines are critical tools for evaluating the mechanical properties, flexibility, and durability of materials, ensuring compliance with stringent safety and quality standards across industries such as automotive, aerospace, manufacturing, and construction. Their role in quality
EEG, EMG, and Evoked Potential Devices Market to Reach US$ 2.6 Bn by 2032 - Persistence Market Research
EEG, EMG, and Evoked Potential Devices Market to Reach US$ 2.6 Bn by 2032 - Pers …
Market Overview The EEG, EMG, and Evoked Potential Devices Market is expanding at a remarkable pace, reflecting the rising prevalence of neurological and neuromuscular disorders and the global emphasis on early diagnosis. Valued at US$ 1.6 billion in 2025, the market is projected to reach US$ 2.6 billion by 2032, registering a CAGR of 7.2% during the forecast period. Growing demand for non-invasive monitoring tools, increased patient awareness, and technological advancements
Oral Cancer Rapid Test Kit Market to Hit US$ 3.3 Bn by 2032 - Persistence Market Research
Oral Cancer Rapid Test Kit Market to Hit US$ 3.3 Bn by 2032 - Persistence Market …
Market Overview The global oral cancer rapid test kit market is gaining significant momentum as early detection becomes a critical factor in improving survival rates. In 2025, the market is projected to reach US$2.3 billion and is forecasted to grow steadily, hitting US$3.3 billion by 2032, at a CAGR of 5.2% during the forecast period. Rising cases of oral cancer-especially in regions with high tobacco consumption and aging populations-are the primary

All 5 Releases


More Releases for Medroxyprogesterone

Medroxyprogesterone Acetate Market, Advancing Women's Health Through Hormonal In …
Market Overview and Outlook The global Medroxyprogesterone Acetate (MPA) Market continues to expand as pharmaceutical companies and healthcare providers rely on this synthetic progestin for a range of women's health applications. This increase is driven by rising awareness of reproductive health, expanding use in contraceptive therapies, and its role in hormone replacement therapy (HRT) for menopausal women. Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a
Global Medroxyprogesterone Acetate Market Imapct of AI and Automation
Medroxyprogesterone Acetate Market Impact of AI and Automation The global Medroxyprogesterone Acetate (MPA) market was valued at approximately USD 1.2 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of around 5.8% from 2023 to 2030. This growth is driven by increasing awareness about contraceptive options, rising prevalence of hormone-related conditions, and expanding pharmaceutical applications. The market's upward trajectory reflects both a growing demand for hormonal
Subcutaneous MedroxyProgesterone Acetate Market Analysis and Future Prospects fo …
The world of the subcutaneous medroxyprogesterone acetate market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing
Global MedroxyProgesterone Market Forecast 2023-2028 Under Inflation
This MedroxyProgesterone market report provides a framework for big corporations to find the most profitable business opportunities. The COVID-19 caused substantial economic turmoil and uncertainty, resulting in increased market unpredictability. Additionally, in order to acquire very detailed data on segment and sub-segment, investigators must do significant research utilizing a regression approach. In-depth research is conducted by financial specialists using both bottom-up and top-down approaches. Get Sample Copy of MedroxyProgesterone Market Report
Global Depot Medroxyprogesterone Injection Market Was Valued at USD 800 million …
According to Precision Business Insights (PBI), the Depot Medroxyprogesterone Injection Market is expected to be worth USD 830 million in 2022, growing at a 4.0% CAGR from 2022 to 2028. Global Depot Medroxyprogesterone Injection Market is segmented into the following types: By Type (Prescriptions & Generic Prescriptions), By End User (Hospital, Pharmacy, & Others), By Application (Contraceptive, Hormone Replacement Therapy, Treatment of Endometriosis, and Other), and Geography (North America, Europe,
Medroxyprogesterone Acetate Market Set to Surge Significantly During 2017 – 20 …
Medroxyprogesterone Acetate Market: Key Market Participants Some of the medroxyprogesterone acetate market participants are Pfizer Inc., Fangtong Pharma.Co.Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd.. The synthetic version of progesterone, 17α-hydroxy-6α-methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected